Virax Biolabs Group Limited (VRAX)
NASDAQ: VRAX · Real-Time Price · USD
1.210
+0.020 (1.68%)
Oct 28, 2026, 1:39 PM EDT - Market open
Virax Biolabs Group Market Cap
Virax Biolabs Group has a market cap or net worth of $964.36 thousand as of October 28, 2026. It is the 49,531st most valuable company in the world and the 6,732nd biggest in the United States. Its market cap has decreased by 61.98% in one year.
Market Cap
964.36K
Enterprise Value
-5.14M
1-Year Change
-61.98%
Global Rank
Country Rank
#6,732 United States
Category
ChartMarket Cap Chart
Since the IPO on July 21, 2022, Virax Biolabs Group's market cap has decreased from $207.01M to $964.36K, a decrease of -99.53%. That is a compound annual growth rate of -71.53%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2026 | 964.36K | -62.43% |
| Dec 31, 2025 | 2.57M | -73.72% |
| Dec 31, 2024 | 9.77M | 269.38% |
| Dec 29, 2023 | 2.64M | -71.76% |
| Dec 30, 2022 | 9.36M | -95.48% |
| Jul 21, 2022 | 207.01M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Genprex | 1.52M |
| Artelo Biosciences | 1.35M |
| Lunai Bioworks | 1.33M |
| Bone Biologics | 1.09M |
| Jaguar Health | 1.06M |
| Endovia Health Sciences | 1.03M |
| Silexion Therapeutics | 995.29K |
| SciSparc | 952.80K |